CGEN
Compugen·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CGEN fundamentals
Compugen (CGEN) released its earnings on Nov 10, 2025: revenue was 1.89M (YoY -88.97%), beat estimates; EPS was -0.07 (YoY -800.00%), beat estimates.
Revenue / YoY
1.89M
-88.97%
EPS / YoY
-0.07
-800.00%
Report date
Nov 10, 2025
CGEN Earnings Call Summary for Q3,2025
- Breakthrough TIGIT strategy: Fc-reduced anti-TIGIT antibodies (COM902) show superior safety vs. Fc-active formats, with Phase III data expected 2026.
- $5B bispecific opportunity: Rilvegostomig (AstraZeneca) in 11 Phase III trials targeting $5B peak sales.
- $758M cytokine potential: GS-0321 (Gilead) IL-18BP program.
- 2027 ovarian cancer readout: MAIA-ovarian interim analysis.
- $86M cash runway: Funds clinical trials until Q3 2027.
EPS
Revenue
Revenue & Expenses
CGEN has released its 2025 Q3 earnings report, with revenue of 1.89M, reflecting a YoY change of -88.96%, and net profit of -6.98M, showing a YoY change of -646.94%. The Sankey diagram below clearly presents CGEN's revenue sources and cost distribution.
Key Indicators
Compugen (CGEN) key financial stats and ratios, covering profitability, financial health, and leverage.
Compugen (CGEN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Compugen (CGEN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Compugen (CGEN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Compugen (CGEN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Compugen (CGEN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Compugen's gross profit margin?What factors drove the changes in Compugen's revenue and profit?What were the key takeaways from Compugen's earnings call?What guidance did Compugen's management provide for the next earnings period?Did Compugen beat or miss consensus estimates last quarter?What is Compugen's latest dividend and current dividend yield?What does Compugen do and what are its main business segments?What is the market's earnings forecast for Compugen next quarter?
